European Equity Partners
VC Fund
London, United Kingdom
European Equity Partners is a private investment firm focused on life science investments. They selectively look to invest in emerging small and mid-sized life science companies. The prospect of growth, proven business traction and a demonstrated promising business model are key investment parameters for us. As an active shareholder they favorcompanies where their experience can assist management accelerate growth and optimize results.EEP assists with their experience, network and capital to facilitate and manage growth more effectively.EEP focuses on investing in few companies so that each of their partner portfolio companies can get their full attention and dedication. As a lead investor EEP is looking to work actively with management and co-shareholders to build world class innovative healthcare companies.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries European Equity Partners invests in
Stages European Equity Partners invests in
Countries European Equity Partners invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Internet 1 (25%)
- Software 1 (25%)
- Wholesale 1 (25%)
- Health Care 1 (25%)
- Biotechnology 1 (25%)
Stage
- Series A 1 (25%)
- Series B 1 (25%)
- Funding Round 1 (25%)
- Venture - Series Unknown 1 (25%)
Country
- Denmark 2 (50%)
- Sweden 1 (25%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
David Kauffmann
Founder Partner
|
Founder Partner | Total investments: 1 | Find email | |
Martin Aagaard
Investment Manager
|
Investment Manager | Total investments: 0 | Find email | |
Neil Boughton
Partner
|
Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Bactolife helps in developing innovative solutions meeting the global need for reducing antimicrobial resistance. Its products are based on minimizing the risk of disease through reduction of virulence, making pathogens unable to establish an active infection. | $32.9M / Series A / Aug 08, 2023 | ||
| Azanta is markets and distributes pharmaceutical products. Its products include Amnisure, Cicatridina, Repadina Plus, Cystistat, Flexi-T, Methadone, Oxandrin, Suplasyn, and development products. | $7.1M / Venture - Series Unknown / Oct 13, 2015 | ||
| PacketFront Software is a young software company with a well-proven solution. PacketFront Software offering for automated multi-vendor networks was created as part of the world’s first public fiber optical network build-out in Sweden in 2001.PacketFront Software products were built to deliver true end-to-end automation in high-volume scenarios,a core characteristic that we have carried with us all the way since then. PacketFront Software products are now a few generations more mature and as solid, scalable, robust and effective as ever. They enhance the agility, competitiveness and profitability of our customers by providing strong automated solutions for complex multi-vendor networks. | $28.5M / Jul 02, 2008 | ||
| PacketFront Software is a young software company with a well-proven solution. PacketFront Software offering for automated multi-vendor networks was created as part of the world’s first public fiber optical network build-out in Sweden in 2001.PacketFront Software products were built to deliver true end-to-end automation in high-volume scenarios,a core characteristic that we have carried with us all the way since then. PacketFront Software products are now a few generations more mature and as solid, scalable, robust and effective as ever. They enhance the agility, competitiveness and profitability of our customers by providing strong automated solutions for complex multi-vendor networks. | $16.5M / Series B / Jun 08, 2004 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does European Equity Partners invest in?
European Equity Partners invests primarily in Internet, Software and Wholesale startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact European Equity Partners?
Public channels for European Equity Partners include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at European Equity Partners?
The team at European Equity Partners includes David Kauffmann (Founder Partner), Martin Aagaard (Investment Manager) and Neil Boughton (Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
